PATENT CLAIM ANALYSIS

Application Number: 15903505
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.

Claim (Index 7):
The method of  claim 1 , wherein IRF5 expression is reduced by administering to the patient a nucleic acid or an analog thereof able to decrease IRF5 expression in the patient.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13565644', '13971334', '10592912', '13258804', '15348345']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7597447681784071
- 35 USC 102 Novelty (BERT): 0.4993206699817143
- Combined Prediction Score: 0.7337023583587379
- Mean Citation Score: 151.23423599999995
- Max Citation Score: 171.21173000000005
- Similarity Product: 103.51807356417898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test